Genomic Vision Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2022
For the full year Total revenue from activity was 1,480,000 against 1,413,000 reported a year ago.
1st Jan change | Capi. | |
---|---|---|
+17.30% | 44.44B | |
-9.89% | 37.99B | |
+37.23% | 37.75B | |
+27.03% | 30.78B | |
-8.64% | 27.38B | |
+12.31% | 26.17B | |
+43.86% | 14.15B | |
+33.20% | 12.59B | |
-7.54% | 11.28B |